Review
doi: 10.1371/journal.pmed.0020339.
Epub 2005 Oct 25.
Cancer vaccines: the next generation of tools to monitor the anticancer immune response
Affiliations
- PMID: 16231977
- PMCID: PMC1261511
- DOI: 10.1371/journal.pmed.0020339
Item in Clipboard
Review
Cancer vaccines: the next generation of tools to monitor the anticancer immune response
PLoS Med.
2005 Oct.
Abstract
Nestle and colleagues discuss a new immunomonitoring tool, described by Chen et al. in PLoS Medicine, that may give insight into the vaccine-induced anticancer immune response.
Conflict of interest statement
Comment on
-
Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.PLoS Med. 2005 Oct;2(10):e265. doi: 10.1371/journal.pmed.0020265. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16162034 Free PMC article. Clinical Trial.
Similar articles
-
Enhancing immune responses for cancer therapy.Cell Mol Immunol. 2007 Jun;4(3):173-84. Cell Mol Immunol. 2007. PMID: 17601371 Review.
-
Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.Med Res Rev. 2008 May;28(3):413-44. doi: 10.1002/med.20110. Med Res Rev. 2008. PMID: 17694549 Review.
-
The ultimate in cancer chemoprevention: cancer vaccines.Cancer Prev Res (Phila). 2010 Apr;3(4):406-9. doi: 10.1158/1940-6207.CAPR-10-0043. Epub 2010 Mar 23. Cancer Prev Res (Phila). 2010. PMID: 20332303 Review.
-
Questions from the fourth son: a clinician reflects on immunomonitoring, surrogate markers and systems biology.Math Biosci Eng. 2011 Apr;8(2):279-87. doi: 10.3934/mbe.2011.8.279. Math Biosci Eng. 2011. PMID: 21631130 Review.
-
Dendritic cell-based cancer vaccination: quo vadis?Expert Rev Vaccines. 2008 Sep;7(7):1041-53. doi: 10.1586/14760584.7.7.1041. Expert Rev Vaccines. 2008. PMID: 18767953 Review.
Cited by
-
Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.Biochim Biophys Acta. 2007 Jul;1773(7):1116-23. doi: 10.1016/j.bbamcr.2007.04.015. Epub 2007 May 1. Biochim Biophys Acta. 2007. PMID: 17555831 Free PMC article.
-
Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach.PLoS Comput Biol. 2012;8(10):e1002742. doi: 10.1371/journal.pcbi.1002742. Epub 2012 Oct 25. PLoS Comput Biol. 2012. PMID: 23133347 Free PMC article.
References
-
- Rastetter W, Molina A, White CA. Rituximab: Expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med. 2004;55:477–503. - PubMed
-
- Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer. 2004;4:371–380. - PubMed
-
- Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348:203–213. - PubMed
-
- Nestle FO, Farkas A, Conrad C. Dendritic-cell-based therapeutic vaccination against cancer. Curr Opin Immunol. 2005;17:163–169. - PubMed
-
- Cerundolo V, Hermans IF, Salio M. Dendritic cells: A journey from laboratory to clinic. Nat Immunol. 2004;5:7–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
